nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—BCHE—peripheral nervous system neoplasm	0.84	1	CbGaD
Ephedrine—Etomidate—SLC2A1—peripheral nervous system neoplasm	0.00624	0.96	CrCbGaD
Ephedrine—SLC18A2—Synaptic Vesicle Pathway—SYP—peripheral nervous system neoplasm	0.00163	0.0807	CbGpPWpGaD
Ephedrine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.00161	0.0797	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.00117	0.058	CbGpPWpGaD
Ephedrine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—TH—peripheral nervous system neoplasm	0.00103	0.0509	CbGpPWpGaD
Ephedrine—ACHE—Biogenic Amine Synthesis—TH—peripheral nervous system neoplasm	0.000918	0.0453	CbGpPWpGaD
Ephedrine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—BCHE—peripheral nervous system neoplasm	0.000883	0.0436	CbGpPWpGaD
Ephedrine—ACHE—Synthesis of PC—BCHE—peripheral nervous system neoplasm	0.000808	0.0399	CbGpPWpGaD
Ephedrine—Urinary retention—Vincristine—peripheral nervous system neoplasm	0.000777	0.00585	CcSEcCtD
Ephedrine—SLC18A2—Dopaminergic Neurogenesis—TH—peripheral nervous system neoplasm	0.000774	0.0383	CbGpPWpGaD
Ephedrine—Hallucination—Isotretinoin—peripheral nervous system neoplasm	0.00077	0.00579	CcSEcCtD
Ephedrine—Hallucination—Tretinoin—peripheral nervous system neoplasm	0.00077	0.00579	CcSEcCtD
Ephedrine—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.000691	0.0052	CcSEcCtD
Ephedrine—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.000691	0.0052	CcSEcCtD
Ephedrine—Irritability—Cisplatin—peripheral nervous system neoplasm	0.000689	0.00519	CcSEcCtD
Ephedrine—Dysuria—Alitretinoin—peripheral nervous system neoplasm	0.000685	0.00516	CcSEcCtD
Ephedrine—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.000682	0.00513	CcSEcCtD
Ephedrine—Tension—Tretinoin—peripheral nervous system neoplasm	0.000661	0.00497	CcSEcCtD
Ephedrine—Tension—Isotretinoin—peripheral nervous system neoplasm	0.000661	0.00497	CcSEcCtD
Ephedrine—Dysuria—Vincristine—peripheral nervous system neoplasm	0.00066	0.00497	CcSEcCtD
Ephedrine—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.000654	0.00492	CcSEcCtD
Ephedrine—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.000654	0.00492	CcSEcCtD
Ephedrine—Muscle spasms—Topotecan—peripheral nervous system neoplasm	0.000653	0.00491	CcSEcCtD
Ephedrine—ADRA1A—Endothelin Pathways—COX2—peripheral nervous system neoplasm	0.000634	0.0313	CbGpPWpGaD
Ephedrine—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.000631	0.00475	CcSEcCtD
Ephedrine—Tremor—Tretinoin—peripheral nervous system neoplasm	0.000631	0.00475	CcSEcCtD
Ephedrine—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.000626	0.00471	CcSEcCtD
Ephedrine—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.000619	0.00466	CcSEcCtD
Ephedrine—Agitation—Tretinoin—peripheral nervous system neoplasm	0.000619	0.00466	CcSEcCtD
Ephedrine—Sweating—Vincristine—peripheral nervous system neoplasm	0.000603	0.00454	CcSEcCtD
Ephedrine—ADRB2—Arf6 trafficking events—NME1—peripheral nervous system neoplasm	0.0006	0.0297	CbGpPWpGaD
Ephedrine—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.000595	0.00448	CcSEcCtD
Ephedrine—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.000595	0.00448	CcSEcCtD
Ephedrine—Delirium—Epirubicin—peripheral nervous system neoplasm	0.000594	0.00447	CcSEcCtD
Ephedrine—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.000583	0.00439	CcSEcCtD
Ephedrine—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.000581	0.00438	CcSEcCtD
Ephedrine—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.000581	0.00438	CcSEcCtD
Ephedrine—Chest pain—Topotecan—peripheral nervous system neoplasm	0.000578	0.00435	CcSEcCtD
Ephedrine—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.000573	0.00432	CcSEcCtD
Ephedrine—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.000573	0.00432	CcSEcCtD
Ephedrine—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.000571	0.0043	CcSEcCtD
Ephedrine—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.000571	0.0043	CcSEcCtD
Ephedrine—Chest pain—Melphalan—peripheral nervous system neoplasm	0.000566	0.00426	CcSEcCtD
Ephedrine—Hallucination—Vincristine—peripheral nervous system neoplasm	0.000562	0.00423	CcSEcCtD
Ephedrine—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.000554	0.00417	CcSEcCtD
Ephedrine—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.000554	0.00417	CcSEcCtD
Ephedrine—Delirium—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.00414	CcSEcCtD
Ephedrine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000536	0.00404	CcSEcCtD
Ephedrine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000536	0.00404	CcSEcCtD
Ephedrine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.000536	0.00403	CcSEcCtD
Ephedrine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.000531	0.004	CcSEcCtD
Ephedrine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.000531	0.004	CcSEcCtD
Ephedrine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000529	0.00399	CcSEcCtD
Ephedrine—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000528	0.00398	CcSEcCtD
Ephedrine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.000524	0.00394	CcSEcCtD
Ephedrine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.000524	0.00394	CcSEcCtD
Ephedrine—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.000524	0.00394	CcSEcCtD
Ephedrine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000517	0.00389	CcSEcCtD
Ephedrine—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.000509	0.00383	CcSEcCtD
Ephedrine—Tension—Alitretinoin—peripheral nervous system neoplasm	0.000501	0.00377	CcSEcCtD
Ephedrine—ACHE—Monoamine Transport—TH—peripheral nervous system neoplasm	0.000501	0.0247	CbGpPWpGaD
Ephedrine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000497	0.00374	CcSEcCtD
Ephedrine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000497	0.00374	CcSEcCtD
Ephedrine—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.000496	0.00373	CcSEcCtD
Ephedrine—SLC6A2—Monoamine Transport—TH—peripheral nervous system neoplasm	0.000495	0.0244	CbGpPWpGaD
Ephedrine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000494	0.00372	CcSEcCtD
Ephedrine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00049	0.00369	CcSEcCtD
Ephedrine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00049	0.00369	CcSEcCtD
Ephedrine—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000488	0.00367	CcSEcCtD
Ephedrine—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000484	0.00364	CcSEcCtD
Ephedrine—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000484	0.00364	CcSEcCtD
Ephedrine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000484	0.00364	CcSEcCtD
Ephedrine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000482	0.00363	CcSEcCtD
Ephedrine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000478	0.0036	CcSEcCtD
Ephedrine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000478	0.0036	CcSEcCtD
Ephedrine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000478	0.0036	CcSEcCtD
Ephedrine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000478	0.00359	CcSEcCtD
Ephedrine—Pain—Topotecan—peripheral nervous system neoplasm	0.000474	0.00357	CcSEcCtD
Ephedrine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000472	0.00355	CcSEcCtD
Ephedrine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00047	0.00354	CcSEcCtD
Ephedrine—Pain—Tretinoin—peripheral nervous system neoplasm	0.00047	0.00354	CcSEcCtD
Ephedrine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000469	0.00353	CcSEcCtD
Ephedrine—Pain—Melphalan—peripheral nervous system neoplasm	0.000464	0.00349	CcSEcCtD
Ephedrine—ACHE—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.000463	0.0229	CbGpPWpGaD
Ephedrine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000457	0.00344	CcSEcCtD
Ephedrine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000453	0.00341	CcSEcCtD
Ephedrine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000453	0.00341	CcSEcCtD
Ephedrine—Agitation—Vincristine—peripheral nervous system neoplasm	0.000452	0.0034	CcSEcCtD
Ephedrine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000451	0.00339	CcSEcCtD
Ephedrine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000446	0.00336	CcSEcCtD
Ephedrine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000442	0.00333	CcSEcCtD
Ephedrine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000441	0.00332	CcSEcCtD
Ephedrine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000438	0.0033	CcSEcCtD
Ephedrine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000435	0.00327	CcSEcCtD
Ephedrine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000435	0.00327	CcSEcCtD
Ephedrine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000435	0.00327	CcSEcCtD
Ephedrine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000433	0.00326	CcSEcCtD
Ephedrine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000428	0.00322	CcSEcCtD
Ephedrine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000425	0.0032	CcSEcCtD
Ephedrine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00042	0.00316	CcSEcCtD
Ephedrine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000418	0.00315	CcSEcCtD
Ephedrine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000407	0.00307	CcSEcCtD
Ephedrine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000407	0.00306	CcSEcCtD
Ephedrine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000403	0.00303	CcSEcCtD
Ephedrine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000398	0.00299	CcSEcCtD
Ephedrine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000397	0.00299	CcSEcCtD
Ephedrine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000394	0.00297	CcSEcCtD
Ephedrine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000394	0.00297	CcSEcCtD
Ephedrine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000391	0.00294	CcSEcCtD
Ephedrine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000389	0.00293	CcSEcCtD
Ephedrine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000388	0.00292	CcSEcCtD
Ephedrine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000384	0.00289	CcSEcCtD
Ephedrine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000383	0.00288	CcSEcCtD
Ephedrine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000383	0.00288	CcSEcCtD
Ephedrine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000377	0.00284	CcSEcCtD
Ephedrine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000371	0.0028	CcSEcCtD
Ephedrine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00037	0.00279	CcSEcCtD
Ephedrine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000369	0.00278	CcSEcCtD
Ephedrine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000367	0.00276	CcSEcCtD
Ephedrine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000366	0.00276	CcSEcCtD
Ephedrine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000363	0.00274	CcSEcCtD
Ephedrine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000363	0.00274	CcSEcCtD
Ephedrine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000363	0.00273	CcSEcCtD
Ephedrine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000362	0.00273	CcSEcCtD
Ephedrine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000358	0.00269	CcSEcCtD
Ephedrine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000356	0.00268	CcSEcCtD
Ephedrine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000355	0.00267	CcSEcCtD
Ephedrine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000352	0.00265	CcSEcCtD
Ephedrine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000349	0.00263	CcSEcCtD
Ephedrine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000349	0.00263	CcSEcCtD
Ephedrine—Rash—Topotecan—peripheral nervous system neoplasm	0.000349	0.00263	CcSEcCtD
Ephedrine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000349	0.00263	CcSEcCtD
Ephedrine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000349	0.00263	CcSEcCtD
Ephedrine—Headache—Topotecan—peripheral nervous system neoplasm	0.000347	0.00261	CcSEcCtD
Ephedrine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000347	0.00261	CcSEcCtD
Ephedrine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000347	0.00261	CcSEcCtD
Ephedrine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000346	0.00261	CcSEcCtD
Ephedrine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000346	0.00261	CcSEcCtD
Ephedrine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000346	0.00261	CcSEcCtD
Ephedrine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000345	0.0026	CcSEcCtD
Ephedrine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000344	0.00259	CcSEcCtD
Ephedrine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000344	0.00259	CcSEcCtD
Ephedrine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000344	0.00259	CcSEcCtD
Ephedrine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000343	0.00258	CcSEcCtD
Ephedrine—Pain—Vincristine—peripheral nervous system neoplasm	0.000343	0.00258	CcSEcCtD
Ephedrine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000343	0.00258	CcSEcCtD
Ephedrine—Rash—Melphalan—peripheral nervous system neoplasm	0.000342	0.00257	CcSEcCtD
Ephedrine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000342	0.00257	CcSEcCtD
Ephedrine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000339	0.00255	CcSEcCtD
Ephedrine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000338	0.00255	CcSEcCtD
Ephedrine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000329	0.00248	CcSEcCtD
Ephedrine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000329	0.00248	CcSEcCtD
Ephedrine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000328	0.00247	CcSEcCtD
Ephedrine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000326	0.00246	CcSEcCtD
Ephedrine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000326	0.00246	CcSEcCtD
Ephedrine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000322	0.00243	CcSEcCtD
Ephedrine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000322	0.00243	CcSEcCtD
Ephedrine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000317	0.00239	CcSEcCtD
Ephedrine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000317	0.00239	CcSEcCtD
Ephedrine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000316	0.00238	CcSEcCtD
Ephedrine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000314	0.00237	CcSEcCtD
Ephedrine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000312	0.00235	CcSEcCtD
Ephedrine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00031	0.00233	CcSEcCtD
Ephedrine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000309	0.00232	CcSEcCtD
Ephedrine—ACHE—ATF-2 transcription factor network—TH—peripheral nervous system neoplasm	0.000307	0.0152	CbGpPWpGaD
Ephedrine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000304	0.00228	CcSEcCtD
Ephedrine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.0003	0.00226	CcSEcCtD
Ephedrine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.00225	CcSEcCtD
Ephedrine—ADRB2—Arf6 signaling events—HGF—peripheral nervous system neoplasm	0.000297	0.0147	CbGpPWpGaD
Ephedrine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000292	0.0022	CcSEcCtD
Ephedrine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00029	0.00218	CcSEcCtD
Ephedrine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.00217	CcSEcCtD
Ephedrine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000288	0.00217	CcSEcCtD
Ephedrine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000286	0.00215	CcSEcCtD
Ephedrine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000283	0.00213	CcSEcCtD
Ephedrine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000283	0.00213	CcSEcCtD
Ephedrine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000281	0.00211	CcSEcCtD
Ephedrine—Pain—Etoposide—peripheral nervous system neoplasm	0.000278	0.00209	CcSEcCtD
Ephedrine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.00209	CcSEcCtD
Ephedrine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.00207	CcSEcCtD
Ephedrine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000274	0.00206	CcSEcCtD
Ephedrine—ADRA1A—Endothelin Pathways—GNAS—peripheral nervous system neoplasm	0.00027	0.0133	CbGpPWpGaD
Ephedrine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000268	0.00202	CcSEcCtD
Ephedrine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000267	0.00201	CcSEcCtD
Ephedrine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000265	0.002	CcSEcCtD
Ephedrine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000265	0.00199	CcSEcCtD
Ephedrine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000263	0.00198	CcSEcCtD
Ephedrine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000262	0.00198	CcSEcCtD
Ephedrine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000261	0.00197	CcSEcCtD
Ephedrine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000261	0.00196	CcSEcCtD
Ephedrine—Selegiline—ABCB1—peripheral nervous system neoplasm	0.000257	0.0396	CrCbGaD
Ephedrine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000257	0.00193	CcSEcCtD
Ephedrine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000255	0.00192	CcSEcCtD
Ephedrine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000255	0.00192	CcSEcCtD
Ephedrine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.00191	CcSEcCtD
Ephedrine—Rash—Vincristine—peripheral nervous system neoplasm	0.000253	0.0019	CcSEcCtD
Ephedrine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000253	0.0019	CcSEcCtD
Ephedrine—Headache—Vincristine—peripheral nervous system neoplasm	0.000251	0.00189	CcSEcCtD
Ephedrine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000247	0.00186	CcSEcCtD
Ephedrine—ACHE—Peptide hormone metabolism—BCHE—peripheral nervous system neoplasm	0.000244	0.012	CbGpPWpGaD
Ephedrine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.00182	CcSEcCtD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000239	0.0118	CbGpPWpGaD
Ephedrine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000238	0.00179	CcSEcCtD
Ephedrine—ACHE—Glycerophospholipid biosynthesis—BCHE—peripheral nervous system neoplasm	0.000237	0.0117	CbGpPWpGaD
Ephedrine—ADRB2—Arf6 signaling events—MET—peripheral nervous system neoplasm	0.000234	0.0116	CbGpPWpGaD
Ephedrine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000233	0.00176	CcSEcCtD
Ephedrine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000229	0.00173	CcSEcCtD
Ephedrine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000226	0.0017	CcSEcCtD
Ephedrine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000224	0.00168	CcSEcCtD
Ephedrine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000224	0.00168	CcSEcCtD
Ephedrine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000219	0.00165	CcSEcCtD
Ephedrine—ADRB2—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.000218	0.0108	CbGpPWpGaD
Ephedrine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000217	0.00163	CcSEcCtD
Ephedrine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000215	0.00162	CcSEcCtD
Ephedrine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000215	0.00162	CcSEcCtD
Ephedrine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.0016	CcSEcCtD
Ephedrine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000211	0.00159	CcSEcCtD
Ephedrine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000207	0.00156	CcSEcCtD
Ephedrine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00154	CcSEcCtD
Ephedrine—Rash—Etoposide—peripheral nervous system neoplasm	0.000205	0.00154	CcSEcCtD
Ephedrine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000205	0.00154	CcSEcCtD
Ephedrine—Headache—Etoposide—peripheral nervous system neoplasm	0.000204	0.00153	CcSEcCtD
Ephedrine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.00153	CcSEcCtD
Ephedrine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.00151	CcSEcCtD
Ephedrine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000201	0.00151	CcSEcCtD
Ephedrine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.0015	CcSEcCtD
Ephedrine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000197	0.00149	CcSEcCtD
Ephedrine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000193	0.00145	CcSEcCtD
Ephedrine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00145	CcSEcCtD
Ephedrine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00019	0.00143	CcSEcCtD
Ephedrine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.00143	CcSEcCtD
Ephedrine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00143	CcSEcCtD
Ephedrine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.0014	CcSEcCtD
Ephedrine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000184	0.00138	CcSEcCtD
Ephedrine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.00137	CcSEcCtD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000181	0.00892	CbGpPWpGaD
Ephedrine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.00134	CcSEcCtD
Ephedrine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000178	0.00134	CcSEcCtD
Ephedrine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00133	CcSEcCtD
Ephedrine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.00132	CcSEcCtD
Ephedrine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.00132	CcSEcCtD
Ephedrine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000174	0.00131	CcSEcCtD
Ephedrine—ADRA1A—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000172	0.00848	CbGpPWpGaD
Ephedrine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.00128	CcSEcCtD
Ephedrine—ACHE—Phospholipid metabolism—BCHE—peripheral nervous system neoplasm	0.000165	0.00817	CbGpPWpGaD
Ephedrine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00124	CcSEcCtD
Ephedrine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.00124	CcSEcCtD
Ephedrine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.00123	CcSEcCtD
Ephedrine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000162	0.00122	CcSEcCtD
Ephedrine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.00121	CcSEcCtD
Ephedrine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00121	CcSEcCtD
Ephedrine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000158	0.00119	CcSEcCtD
Ephedrine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00117	CcSEcCtD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000153	0.00758	CbGpPWpGaD
Ephedrine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.00115	CcSEcCtD
Ephedrine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00113	CcSEcCtD
Ephedrine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00113	CcSEcCtD
Ephedrine—SLC6A2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000149	0.00736	CbGpPWpGaD
Ephedrine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00112	CcSEcCtD
Ephedrine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.0011	CcSEcCtD
Ephedrine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.00109	CcSEcCtD
Ephedrine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000144	0.00108	CcSEcCtD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000144	0.00711	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00014	0.0069	CbGpPWpGaD
Ephedrine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.00105	CcSEcCtD
Ephedrine—SLC18A2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000138	0.00683	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000137	0.00679	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000134	0.00662	CbGpPWpGaD
Ephedrine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.001	CcSEcCtD
Ephedrine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000984	CcSEcCtD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000128	0.00634	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000123	0.00607	CbGpPWpGaD
Ephedrine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000911	CcSEcCtD
Ephedrine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000907	CcSEcCtD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000117	0.00578	CbGpPWpGaD
Ephedrine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000872	CcSEcCtD
Ephedrine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000865	CcSEcCtD
Ephedrine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000864	CcSEcCtD
Ephedrine—SLC6A2—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000114	0.00564	CbGpPWpGaD
Ephedrine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000859	CcSEcCtD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000114	0.00562	CbGpPWpGaD
Ephedrine—ADRB2—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.000113	0.00559	CbGpPWpGaD
Ephedrine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000839	CcSEcCtD
Ephedrine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000815	CcSEcCtD
Ephedrine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000807	CcSEcCtD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000107	0.00527	CbGpPWpGaD
Ephedrine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.0008	CcSEcCtD
Ephedrine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.0008	CcSEcCtD
Ephedrine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000795	CcSEcCtD
Ephedrine—ADRB2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000105	0.00517	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.0001	0.00496	CbGpPWpGaD
Ephedrine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000754	CcSEcCtD
Ephedrine—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	9.78e-05	0.00483	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	9.77e-05	0.00482	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	9.6e-05	0.00474	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.48e-05	0.00469	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—BCHE—peripheral nervous system neoplasm	9.42e-05	0.00465	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	9.39e-05	0.00464	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	9.02e-05	0.00446	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—NTS—peripheral nervous system neoplasm	8.66e-05	0.00428	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.46e-05	0.00418	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	8.3e-05	0.0041	CbGpPWpGaD
Ephedrine—ADRA1A—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	8.09e-05	0.004	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	7.71e-05	0.00381	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	7.09e-05	0.0035	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	6.9e-05	0.00341	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.41e-05	0.00317	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	6.17e-05	0.00305	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	5.91e-05	0.00292	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.72e-05	0.00282	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.71e-05	0.00282	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.6e-05	0.00277	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	5.38e-05	0.00266	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	5.37e-05	0.00265	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.32e-05	0.00263	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	5.15e-05	0.00254	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	5.11e-05	0.00252	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	4.89e-05	0.00242	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	4.88e-05	0.00241	CbGpPWpGaD
Ephedrine—ADRA1A—AMPK Signaling—TP53—peripheral nervous system neoplasm	4.79e-05	0.00236	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.77e-05	0.00236	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	4.7e-05	0.00232	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GNS—peripheral nervous system neoplasm	4.63e-05	0.00229	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	4.6e-05	0.00227	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	4.48e-05	0.00221	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	4.44e-05	0.00219	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—NME1—peripheral nervous system neoplasm	4.44e-05	0.00219	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—COX2—peripheral nervous system neoplasm	4.27e-05	0.00211	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	4.26e-05	0.0021	CbGpPWpGaD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	4.24e-05	0.00209	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	4.19e-05	0.00207	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GNS—peripheral nervous system neoplasm	4.13e-05	0.00204	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	4.11e-05	0.00203	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	4.07e-05	0.00201	CbGpPWpGaD
Ephedrine—ADRA1A—AMPK Signaling—AKT1—peripheral nervous system neoplasm	4.04e-05	0.002	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NME1—peripheral nervous system neoplasm	3.96e-05	0.00196	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	3.89e-05	0.00192	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.84e-05	0.0019	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—COX2—peripheral nervous system neoplasm	3.81e-05	0.00188	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	3.81e-05	0.00188	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.77e-05	0.00186	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	3.76e-05	0.00186	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	3.71e-05	0.00183	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	3.4e-05	0.00168	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	3.37e-05	0.00166	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—HRAS—peripheral nervous system neoplasm	3.25e-05	0.0016	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NTS—peripheral nervous system neoplasm	3.17e-05	0.00157	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.13e-05	0.00155	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	3.11e-05	0.00153	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CD55—peripheral nervous system neoplasm	3.04e-05	0.0015	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.88e-05	0.00142	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ENO2—peripheral nervous system neoplasm	2.81e-05	0.00139	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.66e-05	0.00131	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.64e-05	0.0013	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.62e-05	0.0013	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.57e-05	0.00127	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	2.52e-05	0.00124	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.52e-05	0.00124	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ENO2—peripheral nervous system neoplasm	2.5e-05	0.00124	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.41e-05	0.00119	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.4e-05	0.00119	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—BCHE—peripheral nervous system neoplasm	2.37e-05	0.00117	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.32e-05	0.00115	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.26e-05	0.00112	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—TH—peripheral nervous system neoplasm	2.23e-05	0.0011	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.22e-05	0.0011	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—HRAS—peripheral nervous system neoplasm	2.21e-05	0.00109	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.2e-05	0.00109	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.11e-05	0.00104	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.02e-05	0.000997	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2e-05	0.000986	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—TH—peripheral nervous system neoplasm	1.99e-05	0.000983	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.99e-05	0.000982	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—HRAS—peripheral nervous system neoplasm	1.97e-05	0.000974	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.92e-05	0.000949	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.84e-05	0.000911	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.84e-05	0.000907	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GNAS—peripheral nervous system neoplasm	1.82e-05	0.000899	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ABCB1—peripheral nervous system neoplasm	1.79e-05	0.000882	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.75e-05	0.000862	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.67e-05	0.000823	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GNAS—peripheral nervous system neoplasm	1.62e-05	0.000802	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ABCB1—peripheral nervous system neoplasm	1.59e-05	0.000787	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.47e-05	0.000724	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.43e-05	0.000704	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.38e-05	0.000681	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.36e-05	0.000671	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.25e-05	0.000616	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.21e-05	0.000599	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.18e-05	0.000582	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.12e-05	0.000555	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.03e-05	0.000509	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.82e-06	0.000436	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.66e-06	0.000428	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.29e-06	0.00036	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.16e-06	0.000354	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.85e-06	0.000338	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.45e-06	0.000319	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.27e-06	0.00031	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.21e-06	0.000307	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.7e-06	0.000281	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.66e-06	0.00028	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.34e-06	0.000264	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.21e-06	0.000257	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.19e-06	0.000256	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.14e-06	0.000254	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AKT1—peripheral nervous system neoplasm	4.91e-06	0.000243	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.85e-06	0.00024	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.71e-06	0.000233	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AKT1—peripheral nervous system neoplasm	4.38e-06	0.000217	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.31e-06	0.000213	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.01e-06	0.000198	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.98e-06	0.000197	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.81e-06	0.000188	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.36e-06	0.000166	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.3e-06	0.000163	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.15e-06	0.000156	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.78e-06	0.000137	CbGpPWpGaD
